NCT02607891 - A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 9, 2016

Primary Completion Date

September 11, 2018

Study Completion Date

October 2, 2018

Conditions

Epilepsy

Interventions

DRUG

GWP42003-P

Clear, colorless to yellow solution containing cannabidiol dissolved in the excipients sesame oil and anhydrous ethanol with added sweetener (sucralose) and strawberry flavoring.

DRUG

Placebo

Clear, colorless to yellow solution containing the excipients sesame oil and anhydrous ethanol with added sweetener (sucralose) and strawberry flavoring.

Trial Locations (5)

Unknown

SEIN - Epilepsy Institute in the Netherlands Foundation, Zwolle

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Ruber Internacional, Madrid

Hospital Universitario Virgen del Rocio, Seville

Sahlgrenska University Hospital, Gothenburg